DalCor Pharmaceuticals
DalCor Pharmaceuticals is a drug discovery company in Montreal, Canada, founded in 2015. It has raised $230.0M across 2 rounds, most recently an $80.0M Series D in September 2023.
- Headquarters
- Montreal, Quebec
- Employees
- 1–10
- Founded
- 2015
- Website
- dalcorpharma.com
- Total Funding
- $230.0M
- Last Round
- $80.0M Series DSep 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.
About
DalCor Pharmaceuticals is a biopharmaceutical company focused on addressing cardiovascular disease. Its purpose is to deliver dalcetrapib, a pharmacogenetic precision medicine that targets patients with the ADCY9 AA genotype. Dalcetrapib is being evaluated in the Dal-GenE-2 (DAL-302) Phase 3 cardiovascular clinical outcomes confirmatory trial in 2000 patients with post-acute coronary syndrome who have that genotype. DalCor Pharmaceuticals holds the worldwide exclusive license to develop, manufacture and commercialise dalcetrapib, and a companion diagnostic was developed in conjunction with Roche Molecular Systems.
Summary
It lists 1–10 employees. It has raised $230.0M in total across 2 rounds, most recently a $80.0M Series D round in Sep 2023. Investors include Sanderling Ventures, Fonds de solidarité FTQ and CTI Life Sciences Fund.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2023
Sign up to see all 2 events
Funding: Venture Round through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Verve Therapeutics develops gene-editing treatments for atherosclerotic cardiovascular disease us...
Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...
Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...
SpliceBio develops next-generation gene therapies using its proprietary Protein Splicing platform...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dalcor-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/dalcor-pharmaceuticals" alt="DalCor Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>